Last reviewed · How we verify
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of a Combined Regimen Using ALVAC vCP1452 and AIDSVAX B/B
The purpose of this study is to see if the vaccines tested are safe when given alone and when given together, and how the immune system responds to the vaccines. Vaccines are given to people to try to prevent an infection or disease. Early testing in a few people has shown that the HIV vaccines ALVAC vCP1452 and AIDSVAX B/B seem to be safe to use.
Details
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 330 |
| Completion | 2003-04 |
Conditions
- HIV Infections
Interventions
- ALVAC(2)120(B,MN)GNP (vCP1452)
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
Countries
United States